Skip to main content

Table 3 Relative risk of comorbidities, laboratory parameters and immunological markers in the mortality of HIV/AIDS patients

From: Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon

Characteristic

Death

RR

95% CI

p-value

Yes

No

N = 17

N = 66

Digestive syndromea

8/17 (47%)

16/66 (24%)

3.05

(1.55–6.06)

0.001

Tuberculosisa

12/17 (71%)

25/66 (38%)

4.62

(1.87–11.36)

0.001

IL.8 pg/mLb

90.4 (20–189.0)

26.1 (14.0–90.1)

1.01

(1.00–1.01)

0.007

Lymphocytesb in percentage

20.5 (10.3)

27.4 (13.5)

0.95

(0.91–0.98)

0.003

LDH U/uL** (120 and 246 U/uL)

435 (332–534)

367.5 (300.2–474.2)

1.01

(1.00–1.01)

0.001

  1. Relative risk; CI: confidence interval; and the p-value was calculated using the Poisson regression; LDH: lactate dehydrogenase
  2. aAmong the categorical variables, the statistics were presented as n/N (%); where n = number of patients for whom the variable was positive. N represents total number in each group
  3. bAmong the numerical variables, statistics were presented as median (Q1–Q3) or mean (SD)
  4. **: References value of lactate dehydrogenase (120 and 246 U/uL)